•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Avis Budget Group, Inc. (CAR) Q3 2026 Earnings Call Transcript
What Avis Budget Group (CAR) Said on Its Q3 Earnings Call
Anixa Biosciences Announces Presentation of Ovarian Cancer CAR-T Clinical Trial at ESMO Immuno-Oncology & Advanced Therapies Congress 2026
Compared to Estimates, Avis Budget (CAR) Q3 Earnings: A Look at Key Metrics
Avis Budget Group (CAR) Misses Q3 Earnings Estimates
Allogene Highlights Clinical Progress and Next-Generation Innovation Across Its Off-the-Shelf CAR T Platform at SITC Annual Meeting
Avis Budget Group, Inc. $CAR Stock Sold by Hennessy Advisors Inc.
Cartesian: Maintaining 'Buy' On Descartes-08 MG Data Release And CAR-T Agreement
Earnings Preview: Avis Budget Group (CAR) Q3 Earnings Expected to Decline
Avis First Expands to London Heathrow and Paris Charles de Gaulle Airports
Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial
TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026
Avis Budget Group Inc (CAR) Shares Fall 4.0% -- What GF Score of 72 Tells Investors
New Strong Sell Stocks for October 20th
Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells for Large B-Cell Lymphoma
Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy
Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics
Anixa Biosciences' Ovarian Cancer CAR-T Therapy Inventor to Deliver Keynote at Ovarian Cancer Midwest Focus Conference
Hertz Rebounds 16% From a Record Low; Avis Climbs 5%, Ryder Ticks Up
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial